Back to Search Start Over

α1ACT Is Essential for Survival and Early Cerebellar Programming in a Critical Neonatal Window.

Authors :
Du, Xiaofei
Wei, Cenfu
Hejazi Pastor, Daniel Parviz
Rao, Eshaan R.
Li, Yan
Grasselli, Giorgio
Godfrey, Jack
Palmenberg, Ann C.
Andrade, Jorge
Hansel, Christian
Gomez, Christopher M.
Source :
Neuron. May2019, Vol. 102 Issue 4, p770-770. 1p.
Publication Year :
2019

Abstract

Postnatal cerebellar development is a precisely regulated process involving well-orchestrated expression of neural genes. Neurological phenotypes associated with CACNA1A gene defects have been increasingly recognized, yet the molecular principles underlying this association remain elusive. By characterizing a dose-dependent CACNA1A gene deficiency mouse model, we discovered that α1ACT, as a transcription factor and secondary protein of CACNA1A mRNA, drives dynamic gene expression networks within cerebellar Purkinje cells and is indispensable for neonatal survival. Perinatal loss of α1ACT leads to motor dysfunction through disruption of neurogenesis and synaptic regulatory networks. However, its elimination in adulthood has minimal effect on the cerebellum. These findings shed light on the critical role of α1ACT in facilitating neuronal development in both mice and humans and support a rationale for gene therapies for calcium-channel-associated cerebellar disorders. Finally, we show that bicistronic expression may be common to the voltage-gated calcium channel (VGCC) gene family and may help explain complex genetic syndromes. • α1ACT is essential for early cerebellar development and survival • α1ACT is not crucial in adults, making gene silencing a potential treatment for SCA6 • Several VGCC mRNAs express both VGCCs and transcription factor proteins Du et al. detail how a novel transcription factor, α1ACT, orchestrates postnatal cerebellar development, a finding highly relevant to loss-of-function CACNA1A genetic developmental disorders. The role of α1ACT wanes in adulthood, paving the way for its safe suppression to treat gain-of-function mutations. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08966273
Volume :
102
Issue :
4
Database :
Academic Search Index
Journal :
Neuron
Publication Type :
Academic Journal
Accession number :
136523387
Full Text :
https://doi.org/10.1016/j.neuron.2019.02.036